Table 5 of Nasir, Mol Vis 2014; 20:822-835.

Table 5. Effect of microemulsion and liposomal formulation of tocotrienol (0.03%) on the progression of cataract during 4 weeks period of treatment (Study 2: anticataract efficacy of microemulsion versus liposome).

Groups Week 1 Week 2 Week 3 Week 4
Stage of cataract % of lenses Stage of cataract % of lenses Stage of cataract % of lenses Stage of cataract % of lenses
Normal 0 100 0 100 0 100 0 100
VE 1A
1B 40
60 2A
2B
3 66.67
26.67
6.67 2B
3 10
90 3
4 43.33
56.67
VL 1A
1B 46.67
53.33 1B
2A
2B
3 3.33
60
33.33
3.33 2A
2B
3
4 6.67
40
43.33
10 3
4 40
60
0.03% TTE 0
1A
1B 6.67
83.33
10 1B
1C
2A 20
3.33
76.67 2A
2B
3 33.33
40
26.67 2B
3
4 16.67
63.33
20
0.03% TTL 0
1A
1B 33.33
30
36.67 1A
1B
1C
2A
2B 13.33
33.33
10
30
13.33 1A
1B
2A
2B
3 6.67
6.67
26.67
50
10 1A
2A
2B
3
4 6.67
13.33
36.67
36.67
6.67

VE – vehicle for microemulsion; VL – vehicle for liposomes; TTE – tocotrienol in microemulsion; TTL – tocotrienol in liposomal formulation

Nasir, Mol Vis 2014; 20:822-835. http://www.molvis.org/molvis/v20/822

©2014 Molecular Vision http://www.molvis.org/molvis/

ISSN 1090-0535